Benzinga | May 13, 2021 04:14PM EDT

4D Molecular Therapeutics Q1 EPS $(0.61) Up From $(2.54) YoY, Sales $2.00M Down From $3.50M YoY

4D Molecular Therapeutics (NASDAQ:FDMT) reported quarterly losses of $(0.61) per share. This is a 75.98 percent increase over losses of $(2.54) per share from the same period last year. The company reported $2.00 million in sales this quarter. This is a 42.86 percent decrease over sales of $3.50 million the same period last year.